Eckert & Ziegler SE

1EUZ

Company Profile

  • Business description

    Eckert & Ziegler SE is a provider of isotope technology for medical, scientific, and industrial use. The company is predominantly engaged in the business of cancer therapy, nuclear imaging, and industrial metrology. The company's segments are Medical, Isotope Products, and Other. The Isotope Products segment, which generates key revenue, manufactures and distributes standards and radiation sources for medical and industrial purposes. The Medical segment provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. The Other segment comprises the items of the holding company. Geographically, the company generates a majority of its revenue from Europe and the rest from North America, Asia/Pacific, and other regions.

  • Contact

    Robert-Rossle-Street 10
    BerlinBB13125
    DEU

    T: +49 309410840

    E: [email protected]

    https://www.ezag.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    1,116

Stocks News & Analysis

stocks

Investors punish this ASX player after acquisition

We think the floundering stock price is not reflective of underlying asset value.
stocks

Revenue growth on track for undervalued ASX healthcare stock

Near-term cost growth does not change our long-term view.
stocks

Sales shine but broader macro outlook darkens for this ASX share

US stores are struggling, but our investment thesis hinges on the Australian rollout.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,137.3015.500.17%
CAC 408,245.8018.07-0.22%
DAX 4023,806.99273.64-1.14%
Dow JONES (US)48,185.80275.880.58%
FTSE 10010,603.485.40-0.05%
HKSE25,925.74173.340.67%
NASDAQ22,822.42187.420.83%
Nikkei 22556,948.041,052.721.88%
NZX 50 Index13,163.94109.87-0.83%
S&P 5006,824.6641.850.62%
S&P/ASX 2008,945.2020.800.23%
SSE Composite Index3,991.1424.960.63%

Market Movers